Preventing HCV With Needle/Syringe Programs

Needle/syringe programs (NSPs) have proven to be effective and moderately effective in preventing transmission of HCV infection and minimizing drug-related harms among people who inject ...

Short-Duration Treatment Regimens for HCV

The high cost of DAA-based regimens remains an ethical issue and an obstacle to treatment accessibility. Shorter treatment regimens may offer substantial cost savings, improved ...

Treatment Challenges for Genotype 3 HCV

Data have shown patients with genotype 3 HCV have faster progression of fibrosis and higher rates of cirrhosis, severe steatosis, and hepatocellular carcinoma.

Hepatocellular Carcinoma: Treatment Challenges

Despite continual efforts aimed at finding new treatment options, HCC still has a very low 5-year survival rate, less than 20%, as many patients are ...

Hepatitis B: Current State of Affairs

One of the main challenges in managing and controlling hepatitis B infection today is identifying people who are infected and ensuring that they have access ...

Update on Pediatric HCV: Q&A With the Experts

Experts discuss screening, treatment, and other considerations in pediatric HCV.

Treating Rheumatic Manifestations of Hepatitis C Virus

Patients with HCV are at risk for several extrahepatic sequelae. Find out what they are and the new treatment options for managing HCV in patients ...

Latest News

ACP, CDC Provides Best Practice Advice on Hepatitis B Management

ACP, CDC Provides Best Practice Advice on Hepatitis B Management

Screening, vaccination, and linkage to care will reduce the high costs associated with hepatitis B infection.

Effectiveness of Ledipasvir/Sofosbuvir for Acute HCV Infection in HIV

Effectiveness of Ledipasvir/Sofosbuvir for Acute HCV Infection in HIV

Study evaluated the optimal duration of ledipasvir/sofosbuvir for the treatment of acute hepatitis C virus (HCV) infection in HIV.

Preventing HBV Reactivation During Immunosuppressive Treatment

Preventing HBV Reactivation During Immunosuppressive Treatment

Although it is commonly accepted that lamivudine prophylaxis should be started a few weeks before chemotherapy is administered, the best time for lamivudine discontinuation is still controversial.

FDA Approves New Hepatitis B Vaccine for Adults

FDA Approves New Hepatitis B Vaccine for Adults

The FDA approves new hepatitis B virus vaccine for adults.

Increasing HCV Screening Using Electronic Health Record Prompts

Increasing HCV Screening Using Electronic Health Record Prompts

The rates of anti-HCV orders and tests were collected from 4 medical specialties within a 30 mile radius of University of Michigan, Ann Arbor campus.

A New Treatment Option for Patients With HCV and Severe Renal Impairment

A New Treatment Option for Patients With HCV and Severe Renal Impairment

Glecaprevir, an NS3/4A protease inhibitor, and pibrentasvir, an NS5A inhibitor, exhibit potent antiviral activity across all six major HCV genotypes.

Hepatitis C Transmission With Increased Risk Donor Organs Examined

Hepatitis C Transmission With Increased Risk Donor Organs Examined

Given the ongoing shortage of liver grafts, transplantation from HCV increased-risk donors to anti-HCV-negative recipients could potentially expand the donor pool.

Aspirin May Lower Risk of HBV-Related Hepatocellular Carcinoma

Aspirin May Lower Risk of HBV-Related Hepatocellular Carcinoma

Patients who take aspirin may significantly reduce their risk of hepatitis B-related hepatocellular carcinoma.

Using VA Models of Care for Reducing HCV Burden

Using VA Models of Care for Reducing HCV Burden

The US VA has developed models of care that can be used to reduce the overall burden of HCV infection.

Antiviral Therapies Can Improve Fertility, Pregnancy Outcomes in HCV+ Women

Antiviral Therapies Can Improve Fertility, Pregnancy Outcomes in HCV+ Women

Researchers from the United States and Italy examined 3 cohorts of women to study rates of miscarriage and infertility in HCV, and how early antiviral treatment can affect them.

Sign Up for Free e-newsletters